Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | THRD | Stock Option (right to buy) | Award | $0 | +13.7K | $0.00 | 13.7K | Oct 26, 2022 | Common Stock | 13.7K | $17.83 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The option vests over a 8-month period: 1/8th on October 26, 2022, after which 1/8th of the total shares vest monthly, subject to continued service through each vesting date. |
F2 | The Reporting Person is a member of Atlas Venture Life Science Advisors, LLC ("Atlas") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any. |